Cancer of the prostate

Sergio Bracarda, Ottavio De Cobelli, Carlo Greco, Tommaso Prayer-Galetti, Riccardo Valdagni, Gemma Gatta, Filippo De Braud, Georg Bartsch

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate cancer (HPC) have been identified. A suspect of prostate cancer may derive from elevated serum prostate-specific antigen (PSA) values and/or a suspicious digital rectal examination (DRE) finding. For a definitive diagnosis, however, a positive prostate biopsy is requested. Treatment strategy is defined according to initial PSA stage, and grade of the disease and age and general conditions of the patient. In localized disease, watchful waiting is indicated as primary option in patients with well or moderately differentiated tumours and a life expectancy

Original languageEnglish
Pages (from-to)379-396
Number of pages18
JournalCritical Reviews in Oncology/Hematology
Volume56
Issue number3
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Prostatic Neoplasms
Prostate-Specific Antigen
Prostate
Watchful Waiting
Digital Rectal Examination
Neoplasms
Life Expectancy
Diet
Carcinoma
Biopsy
Serum
Genes
Therapeutics
Familial Prostate cancer

Keywords

  • Chemotherapy
  • Follow-up
  • Hormone-therapy
  • Prostate neoplasms
  • Prostate-specific antigen
  • Radical prostatectomy
  • Radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Cancer of the prostate. / Bracarda, Sergio; De Cobelli, Ottavio; Greco, Carlo; Prayer-Galetti, Tommaso; Valdagni, Riccardo; Gatta, Gemma; De Braud, Filippo; Bartsch, Georg.

In: Critical Reviews in Oncology/Hematology, Vol. 56, No. 3, 12.2005, p. 379-396.

Research output: Contribution to journalArticle

Bracarda, Sergio ; De Cobelli, Ottavio ; Greco, Carlo ; Prayer-Galetti, Tommaso ; Valdagni, Riccardo ; Gatta, Gemma ; De Braud, Filippo ; Bartsch, Georg. / Cancer of the prostate. In: Critical Reviews in Oncology/Hematology. 2005 ; Vol. 56, No. 3. pp. 379-396.
@article{d543ca44aacf4ce09670cfb55fd494bd,
title = "Cancer of the prostate",
abstract = "Prostate carcinoma, with about 190,000 new cases occurring each year (15{\%} of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate cancer (HPC) have been identified. A suspect of prostate cancer may derive from elevated serum prostate-specific antigen (PSA) values and/or a suspicious digital rectal examination (DRE) finding. For a definitive diagnosis, however, a positive prostate biopsy is requested. Treatment strategy is defined according to initial PSA stage, and grade of the disease and age and general conditions of the patient. In localized disease, watchful waiting is indicated as primary option in patients with well or moderately differentiated tumours and a life expectancy",
keywords = "Chemotherapy, Follow-up, Hormone-therapy, Prostate neoplasms, Prostate-specific antigen, Radical prostatectomy, Radiotherapy",
author = "Sergio Bracarda and {De Cobelli}, Ottavio and Carlo Greco and Tommaso Prayer-Galetti and Riccardo Valdagni and Gemma Gatta and {De Braud}, Filippo and Georg Bartsch",
year = "2005",
month = "12",
doi = "10.1016/j.critrevonc.2005.03.010",
language = "English",
volume = "56",
pages = "379--396",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Cancer of the prostate

AU - Bracarda, Sergio

AU - De Cobelli, Ottavio

AU - Greco, Carlo

AU - Prayer-Galetti, Tommaso

AU - Valdagni, Riccardo

AU - Gatta, Gemma

AU - De Braud, Filippo

AU - Bartsch, Georg

PY - 2005/12

Y1 - 2005/12

N2 - Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate cancer (HPC) have been identified. A suspect of prostate cancer may derive from elevated serum prostate-specific antigen (PSA) values and/or a suspicious digital rectal examination (DRE) finding. For a definitive diagnosis, however, a positive prostate biopsy is requested. Treatment strategy is defined according to initial PSA stage, and grade of the disease and age and general conditions of the patient. In localized disease, watchful waiting is indicated as primary option in patients with well or moderately differentiated tumours and a life expectancy

AB - Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate cancer (HPC) have been identified. A suspect of prostate cancer may derive from elevated serum prostate-specific antigen (PSA) values and/or a suspicious digital rectal examination (DRE) finding. For a definitive diagnosis, however, a positive prostate biopsy is requested. Treatment strategy is defined according to initial PSA stage, and grade of the disease and age and general conditions of the patient. In localized disease, watchful waiting is indicated as primary option in patients with well or moderately differentiated tumours and a life expectancy

KW - Chemotherapy

KW - Follow-up

KW - Hormone-therapy

KW - Prostate neoplasms

KW - Prostate-specific antigen

KW - Radical prostatectomy

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=27944474820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27944474820&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2005.03.010

DO - 10.1016/j.critrevonc.2005.03.010

M3 - Article

VL - 56

SP - 379

EP - 396

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 3

ER -